Localization of the endothelin system in human diffuse astrocytomas

Cancer

Volumn 104, Issue 5, 2005, Pages 1049-1057

  Naidoo, Vinogran ^a   Naidoo, Strinivasen ^a   Mahabeer, Rajeshree ^a   Raidoo, Deshandra Munsamy ^b  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

^b UNIVERSITY OF SOUTH DAKOTA   (United States)

Author keywords

Immunocytochemistry; In situ RT PCR; Tumor astrocytes; Vasoconstriction

Indexed keywords

ENDOTHELIN; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; ENDOTHELIN CONVERTING ENZYME; MESSENGER RNA; POLYCLONAL ANTIBODY;

ADULT; ANGIOGENESIS; ANTIBODY LABELING; APOPTOSIS; ARTICLE; ASTROCYTOMA; CANCER GRADING; CARCINOGENESIS; CYTOPLASM; ENDOTHELIUM CELL; FEMALE; GENE EXPRESSION; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MENINGIOMA; MITOGENESIS; NEUROBLASTOMA; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SYNTHESIS; TUMOR CELL; VASODILATATION;

ADULT; ASPARTIC ENDOPEPTIDASES; ASTROCYTOMA; ENDOTHELIN-1; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; METALLOENDOPEPTIDASES; RECEPTOR, ENDOTHELIN A; RECEPTOR, ENDOTHELIN B; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 23844535468     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.21277     Document Type: Article

References (54)

1. Inoue T, Yanagisawa M, Kimura S, et al. The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Nat Acad Sci USA. 1989;86:2863-2867.
2. Gray AG, Webb DJ. The endothelin system and its potential as a therapeutic target in cardiovascular disease. Pharmacol Ther. 1996;72:109-148.
3. Takahashi M, Ghatei MA, Jones PM, et al. Endothelin in human brain and pituitary gland: presence of immunoreactive endothelin, endothelin messenger ribonucleic acid, and endothelin receptors. J Clin Endocrinol Metab. 1991a;72: 693-699.
4. Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent, vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988;332:411-415.
5. Levin ER. Endothelins. N Engl J Med. 1995;333:356-363.
6. Ahmed SI, Thompson J, Coulson JM, Woll PJ. Studies on the expression of endothelin, its receptor subtypes, and converting enzymes in lung cancer and in human bronchial epithelium. Am J Respir Cell Mol Biol. 2000;22:422-431.
7. Giaid A, Hamid QA, Springall DR, et al. Detection of endothelin immunoreactivity and mRNA in pulmonary tumors. J Pathol. 1990;162:15-22.
8. Kakugawa Y, Giaid A, Yanagisawa M, et al. Expression of endothelin-1 in pancreatic tissue of patients with chronic pancreatitis. J Pathol. 1996;178:78-83.
9. Rossi GP, Belloni AS, Albertin G, et al. Endothelin-;1 and its receptors A and B in human aldosterone-producing adenomas. Hypertension. 1995;25:842-847.
10. Rosano L, Varmi M, Salani D, et al. Endothelin-1 induces tumour proteinase activation and invasiveness of ovarian carcinoma cells. Cancer Res. 2001;61:8340-8346.
11. Kusuhara M, Yamaguchi K, Nagasaki K, et al. Production of endothelin in human cancer cell lines. Cancer Res. 1990;50: 3257-3261.
12. Nelson J, Chan-;Tack K, Hedican S, et al. Endothelin-;1 production and decreased endothelin B receptor expression in advanced prostate cancer. Cancer Res. 1996;56:663-668.
13. Shankar A, Loizidou M, Aliev G, Fredericks S, Holt D, Boulous PB. Raised endothelin-1 levels in patients with colorectal liver metastases. Br J Surg. 1998;85:502-506.
14. Bagnato A, Tecce R, Moretti C, Di Castro V, Spergel DJ, Catt K. Autocrine actions of endothelin-;1 as a growth factor in human ovarian carcinoma cell lines. Clin Cancer Res. 1995; 1:1059-1066.
15. Zhao YD, Springall DR, Hamid Q, Levene M, Polak JM. Localization and characterization of endothelin-1 receptor binding in the blood vessels of human pulmonary tumors. J Cardiovasc Pharmacol. 1995;26:S341-S345.
16. Shichiri M, Kato H, Marumo F, Hirata Y. Endothelin-1 as an autocrine/paracrine apoptosis survival factor for endothelial cells. Hypertension. 1998a;30:l198-1203.
17. Wu-Wong JR, Chiou WJ, Dickinson R, Opgenorth TJ. Endothelin attenuates apoptosis in human smooth muscle cells. Biochem J. 1997;328:733-737.
18. Supattapone S, Simpson AWM, Ashley CC. Free calcium rise and mitogenesis in glial cells caused by endothelin. Biochem Biophys Res Commun. 1989;165:1115-1122.
19. Ehrenreich H, Kehrl JH, Anderson RW, et al. A vasoactive peptide, endothelin-3, is produced by and specifically binds to primary astrocytes. Brain Res. 1991;538:54-58.
20. Hosli E, Hosli L. Autoradiographic evidence for endothelin receptors on astrocytes in cultures of rat cerebellum, brain-stem and spinal cord. Neurosci. Lett. 1991;129:55-58.
21. MacCumber MW, Ross CA, Snyder SH. Endothelin in brain: receptors, mitogenesis, and biosynthesis in glial cells. Proc Nat Acad Sci USA. 1990;87:2359-2363.
22. Giaid A, Gibson SJ, Herrero MT, et al. Topographical localization of endothelin mRNA and peptide immunoreactivity in neurones of the human brain. Histochemistry. 1991;95: 303-314.
23. Deschepper CP, Houweling AD, Picard S. The membranes of cultured rat brain astrocytes contain endothelin-converting enzyme activity. Eur J Pharmacol. 1995;275:61-66.
24. Hosli L, Hosli E, Lefkovits M, Wagner S. Electrophysiological evidence for the existence of receptors for endothelin and vasopressin on cultured astrocytes of rat spinal cord and brainstem. Neurosci Lett. 1991;131:193-195.
25. rd ed. Edinburgh: Churchill Livingstone, 1978.
26. Sone M, Takahashi K, Totsune K, et al. Expression of endothelin-1 and endothelin receptors in cultured human glioblastoma cells. J Cardiovasc Pharmacol. 2000;36:390-392.
27. Stiles JD, Ostrow PT, Balos LL, et al. Correlation of endothelin-;1 and transforming growth factor beta 1 with malignancy and vascularity in human gliomas. J Neuropathol Exp Neurol. 1997;56:435-439.
28. Li JM, Wu XL, Zhu QJ, Wang QI. [Endothelin-;1 expression and quantitative analysis in astrocytomas.] [abstract]. Ai Zeng 2002;21:1109-1111.
29. Egidy G, Eberl LP, Valdenaire O, et al. The endothelin system in human glioblastoma. Lab Invest. 2000;80:1681-1689.
30. Pagotto U, Arzberger T, Hopfner U, Weindl A, Stalla GK. Cellular localisation of endothelin receptor mRNAs (ETA and ETB) in brain tumours and normal human brain. J Cardiovasc Pharmacol. 1995;26:S104-S106.
31. Takahashi K, Totsune K, Kitamuro T, Sone M, Murakami O, Shibahara S. Three vasoactivc peptides, endothelin-;1, adrenomedullin and urotensin-II, in human tumour cell lines of different origin: expression and effects on proliferation. Clin Sci. 2002;103:35S-38S.
32. Kitagawa N, Tsutsumi K, Niwa M, et al. Expression of a functional endothelin (ETA) receptor in human meningiomas. J Neurosurg. 1994;80:723-731.
33. Tsutsumi K, Niwa M, Kitagawa N, et al. Enhanced expression of an endothelin ETA receptor in capillaries from human glioblastoma: a quantitative receptor autoradiographic analysis using a radioluminographic imaging plate system. J Neurochem. 1994;63:2240-2247.
34. Harland SP, Kuc RE, Pickard JD, Davenport AP. Expression of endothelin(A) receptors in human gliomas and meningiomas, with high affinity for the selective antagonist PD156707. Neurosurgery. 1998;43:890-898.
35. Kleihues P, Louis D, Scheithauer B, et al. The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol. 2002;61:215-225.
36. Daumas-Duport C, Scheithauer B, O'Fallon J, Kelly P. Grading of astrocytomas: a simple and reproducible method. Cancer. 1998;62:2152-2165.
37. Karet FE, Davenport AP. Localisation of endothelin peptides in human kidney. Kidney Int. 1996;49:382-387.
38. Sunnergren KP, Word RA, Sambrook JF, MacDonald PC, Casey MK. Expression and regulation of endothelin precursor mRNA in avascular amnion. Mol Cell Endocrin. 1990;68: 7-14.
39. Salamonsen LA, Butt AR, Macpherson AM, Rogers PAW, Findlay JK. Immunolocalisation of the vasoconstrictor endothelin in human endometrium during the menstrual cycle and in umbilical cord at birth. Am J Obstet Gynecol. 1992;167:163-167.
40. Korth P, Bohle RM, Corvol P, Pinet F. Cellular distribution of endothelin-;converting enzyme-;1 in human tissues. J Histochem Cytochem. 1999;47:447-461.
41. Naicker S, Gathiram P, Naidoo S, Nadar A, Müller-Esterl W, Bhoola KD. ET-1 and endothelin receptor status in kidney transplants undergoing acute rejection. Immunopharmacology. 1999;44:67-74.
42. Naidoo V, Naidoo S, Mahabeer R, Raidoo DM. Cellular distribution of the endothelin system in human brain. J Chem Neuroanat. 2004;27:87-89.
43. Horstmeyer A, Cramer H, Sauer T, Muller-Esterl W, Schroeder C. Palmitoylation of endothelin receptor. Amer J Biol Chem. 1996;271:20811-20819.
44. Cramer H, Muller-Esterl W, Schroeder C. Subtype-specific desensitization of human endothelin ETA and ETB receptors reflects differential receptor phosphorylation. Biochemistry. 1997;36:13325-13332.
45. Naidoo V, Mahabeer R, Raidoo DM. Cellular distribution of endothelin-1 mRNA in human brain by in situ RT-PCR. Metab. Brain Dis. 2001;16:207-218.
46. Naidoo V, Naidoo S, Raidoo D. Immunolocalisation of endothelin-1 in human brain. J Chem Neuroanat. 2004;27:193-200.
47. Lee M-E, de la Monte SM, Ng S-C, Bloch KD, Quertermous T. Expression of the potent vasoconstrictor endothelin in the central nervous system. J Clin Invest. 1990;80:141-147.
48. Maguire JJ, Kuc RE, Davenport AP. Affinity and selectivity of PD156707, a novel nonpeptide endothelin antagonist, for human ETA and ETB receptors. J Pharmacol Experimental Therapeutics. 1997;280:1102-1108.
49. Howe DG, McCarthy KD. Retroviral inhibition of cAMP-dependent protein kinase inhibits myelination but not Schwann cell mitosis stimulated by interaction with neurons. J Neurosci. 2000;20:3513-3521.
50. Porter JT, McCarthy KD. Astrocytic neurotransmitter receptors in situ and in vivo. Prog Neurobiol. 1997;51:439-455.
51. Naus CC, Bechberger JF, Zhang Y, et al. Altered gap junctional communication, intracellular signaling, and growth in cultured astrocytes deficient in connexin 43. J Neurosci Res. 1997;49:520-540.
52. Lin JH, Weigel H, Cotrina ML, et al. Gap-junction-mediated propagation and amplificution of cell injury. Nat Neurosci. 1998;1:494-500.
53. Blomstrand F, Giaume C, Hansson E, Ronnback L. Distinct pharmacological properties of ET-1 and ET-3 on astroglial gap junctions and Ca2+ signaling. Am J Physiol. 1999;277: 616-627.
54. Teixeira A, Chaverot N, Strosberg AD, Cazaubon S. Differential regulation of cyclin D1 and D3 expression in the control of astrocyte proliferation induced by endothelin-1. J Neurochem. 2000;74:1034-1040.